Next Article in Journal
Previous Article in Journal
Molecules 2014, 19(5), 5806-5820; doi:10.3390/molecules19055806
Article

Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides

1
, 2
, 3
, 4
, 1,* , 5
, 5
, 5
 and 6
Received: 6 February 2014; in revised form: 14 April 2014 / Accepted: 16 April 2014 / Published: 6 May 2014
(This article belongs to the Section Organic Synthesis)
View Full-Text   |   Download PDF [305 KB, uploaded 18 June 2014]   |   Browse Figures
Abstract: Because of the need for more effective and less harmful antifungal therapies, and interest in the synthesis of new carboximidamides, the goal of this study was to determine the antifungal and anti-enzyme activities of some new pyrazole carboximidamides and their cytotoxicity. For this purpose, tests were performed to evaluate: minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC); production of proteinases and phospholipase, and cytotoxicity of the extracts. Data were analyzed by ANOVA and Tukey Tests (α = 5%). The results were: MIC and MFC ≥ 62.5 μg/mL (C. albicans, C. parapsilosis, C. famata, C. glabrata, and Rhodotorula mucillaginosa) and MIC and MFC ≥ 15.6 μg/mL (C. lipolytica). The values of proteinase and phospholipase (Pz) of C. albicans before and after exposure to the compounds were: 0.6 (±0.024) and 0.2 (±0.022) and 0.9 (±0.074) and 0.3 (±0.04), respectively. These proteinase results were not significant (p = 0.69), but those of phospholipase were (p = 0.01), and 15.6 μg/mL was the most effective concentration. The cytotoxicity means were similar among the tests (p = 0.32). These compounds could be useful as templates for further development through modification or derivatization to design more potent antifungal agents. Data from this study provide evidence that these new pyrazole formulations could be an alternative source for the treatment of fungal infections caused by Candida. However, a specific study on the safety and efficacy of these in vivo and clinical trials is still needed, in order to evaluate the practical relevance of the in vitro results.
Keywords: pyrazoles; Candida albicans; antifungal activity; anti-enzyme activity pyrazoles; Candida albicans; antifungal activity; anti-enzyme activity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Oliveira, S.; Pizzuti, L.; Quina, F.; Flores, A.; Lund, R.; Lencina, C.; Pacheco, B.S.; de Pereira, C.M.P.; Piva, E. Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides. Molecules 2014, 19, 5806-5820.

AMA Style

Oliveira S, Pizzuti L, Quina F, Flores A, Lund R, Lencina C, Pacheco BS, de Pereira CMP, Piva E. Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides. Molecules. 2014; 19(5):5806-5820.

Chicago/Turabian Style

Oliveira, Simone; Pizzuti, Lucas; Quina, Frank; Flores, Alex; Lund, Rafael; Lencina, Claiton; Pacheco, Bruna S.; de Pereira, Claudio M.P.; Piva, Evandro. 2014. "Anti-Candida, Anti-Enzyme Activity and Cytotoxicity of 3,5-Diaryl-4,5-dihydro-1H-pyrazole-1-carboximidamides." Molecules 19, no. 5: 5806-5820.



Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert